Focused Ultrasound-activated Extracellular Vesicles-nanoparticle Hybrids for Targeted Brain Drug Delivery:...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• The blood-brain barrier (BBB) poses a significant challenge for targeted drug delivery in the brain.
• Focused ultrasound (FUS) offers a non-invasive method for temporary BBB modulation.
• Hybrid extracellular vesicle-nanoparticle (EV-NP) platforms combine biological and synthetic advantages for drug delivery.

Purpose of the Study:

• To review engineering approaches for FUS-activated EV-NP hybrids.
• To examine translational challenges and molecular mechanisms of these novel drug delivery systems.
• To highlight advancements in targeted intracerebral drug delivery.

Main Methods:

• Focused ultrasound (FUS) utilizes acoustic cavitation for reversible BBB opening.
• EV-NP hybrids are engineered with features like thermosensitive lipids, ligand-mediated targeting, and stimuli-responsive surfaces.
• Preclinical models are used to evaluate therapeutic efficacy and brain penetration.

Main Results:

• FUS-activated EV-NP hybrids demonstrate enhanced drug penetration across the BBB (up to 90%).
• These systems show improved therapeutic indices and prolonged drug retention compared to conventional methods.
• Engineering advancements enhance biodistribution and targeted release accuracy.

Conclusions:

• FUS-activated EV-NP hybrids represent a promising platform for precision neuropharmacology.
• Further research is needed to address challenges in large-scale production, standardization, and regulatory validation.
• Integration of synthetic biology, microfluidics, and AI can optimize design and scalability for clinical translation.